Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * LORES ENRIQUE	2. Issuer Name and Ticker or Trading Symbol HP INC [ HPQ ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) President and CEO
(Last)          (First)          (Middle) C/O HP INC. 1501 PAGE MILL RD	3. Date of Earliest Transaction (MM/DD/YYYY) 12/7/2021
(Street) PALO ALTO, CA 94304 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/7/2021		M		190528.00	A	$0.00	743429.00	D
Common Stock	12/7/2021		F		90225.00 (1)	D	$37.29	653204.00	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	12/7/2021		A		120676.00		(3)	(3)	Common Stock	120676.00	(3)	120676.00	D
Performance Adjusted Restricted Stock Units	(4)	12/7/2021		A		108441.00		(4)	(4)	Common Stock	108441.00	(4)	108441.00	D
Performance Contingent Stock Options	$37.29	12/7/2021		A		498543.00		(5)	(5)	Common Stock	498543.00	(5)	498543.00	D
Restricted Stock Units	(2)	12/7/2021		M			78078.00	(6)	(6)	Common Stock	78078.00	(6)	152028.00	D
Restricted Stock Units	(2)	12/7/2021		M			76341.00	(7)	(7)	Common Stock	76341.00	(7)	71545.00	D
Restricted Stock Units	(2)	12/7/2021		M			36109.00	(8)	(8)	Common Stock	36109.00	(8)	0.00	D

Explanation of Responses:
(1)	Shares withheld by HP to satisfy tax withholding upon vesting.
(2)	Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
(3)	On 12/7/2021, the reporting person was granted 120,676 RSUs, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
(4)	On 12/7/2021, the reporting person was granted 108,441 performance adjusted restricted stock units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
(5)	The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.
(6)	As previously reported, on 12/7/2020, the reporting person was granted 228,041 RSUs, 76,013 of which vested on 12/7/2021 and 76,014 of which is scheduled to vest on each of 12/7/2022 and 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 2,065 vested dividend equivalent rights.
(7)	As previously reported, on 12/6/2019, the reporting person was granted 214,634 RSUs, 71,544 of which vested on 12/7/2020, 71,545 vested on 12/7/2021 and 71,545 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 4,796 vested dividend equivalent rights.
(8)	As previously reported, on 12/7/2018, the reporting person was granted 98,561 RSUs, 32,853 of which vested on 12/7/2019, 32,854 of which vested on 12/7/2020 and 32,854 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 3,255 vested dividend equivalent rights.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
LORES ENRIQUE C/O HP INC. 1501 PAGE MILL RD PALO ALTO, CA 94304	X		President and CEO

Signatures
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores		12/9/2021
**Signature of Reporting Person		Date